Photo: Juliana Thomas
Triple-negative breast cancer (TNBC), an aggressive form of the disease that is more common in people under 40 who are Black or have a BRCA1 mutation, is more likely to return after treatment and has a worse prognosis than other breast cancers. Sylvia Adams, MD, director of the Breast Cancer Center at 嘿嘿视频 Health鈥檚 Perlmutter Cancer Center, talks to CBS New York about the addition of immunotherapy to the standard chemotherapy, an advance in treatment that was beneficial to Rene Williams, one of her patients.
鈥淲e actually had a very early, good, clinical response and were able to take her to surgery earlier,鈥 says Dr. Adams, also a professor in the at NYU Grossman School of Medicine. 鈥淎nd she had no residual cancer at time of surgery, which predicts an excellent outcome and cure.鈥
Watch more on .
